Shi Hao, Niu Yue, Huang Qian, Yang Zheng-Ming, Yang Li
Department of Acupuncture-Moxibustion, 3Department of Gastroenterology, Lianyungang Hospital of TCM Affiliated to Kangda College of Nanjing Medical University, Lianyungang 222000, Jiangsu Province, China; Clinical Medicine Department of Kangda College of Nanjing Medical University, Lianyungang 222000, Jiangsu Province.
Department of Gastroenterology, Lianyungang Hospital of TCM Affiliated to Kangda College of Nanjing Medical University, Lianyungang 222000, Jiangsu Province, China.
Zhongguo Zhen Jiu. 2021 Sep 12;41(9):984-90. doi: 10.13703/j.0255-2930.20200904-k0001.
To compare the clinical therapeutic effect on diarrhea-predominant irritable bowel syndrome (IBS-D) of spleen deficiency and damp excess among fire needling therapy with filiform needle combined with acupoint application therapy, simple acupoint application therapy and pinaverium bromide tablets, and explore the mechanism on the improvements in IBS-D.
A total of 150 patients with IBS-D of spleen deficiency and damp excess were randomized into a combined treatment group (50 cases, 14 cases dropped off), an acupoint application group (50 cases, 16 cases dropped off ) and a western medication group (50 cases, 13 cases dropped off ). In the western medication group, pinaverium bromide tablets were prescribed for oral administration, 50 mg per time, three times a day. In the acupoint application group, the herbal plaster of powder mixed with fresh ginger juice was placed on Shenque (CV 8), once every two days. In the combined treatment group, on the base of the treatment as the acupoint application group, the fire needling therapy with filiform needle was exerted at Tianshu (ST 25), Shangjuxu (ST 37), Yinlingquan (SP 9) and Dachangshu (BL 25), once every two days. The duration of treatment in each group was 4 weeks. Separately, before treatment and after 7 and 28 days of treatment, the score of clinical symptoms and the score of quality of life scale for IBS (IBS-QOL) were observed in each group. Before treatment and after 28 days of treatment, the levels of , and T lymphocytes, and the ratio of / in peripheral blood of patients were detected successively; as well as the expressions of 5-HT3R mRNA and 5-HT4R mRNA in colon mucosal tissues in each group separately.
Except the score for abdominal pain in the acupoint application group and the scores for abdominal pain and abdominal distention in the western medication group after 7 days of treatment, the scores for abdominal pain, abdominal distention, defecation frequency, stool form and incomplete bowel movement after 7 and 28 days of treatment were all reduced as compared with those before treatment in each group separately (<0.05). After 7 days of treatment, the scores for abdominal distention, defecation frequency and stool form in the combined treatment group were all lower than those in the western medication group (<0.05). After 28 days of treatment, the score of each clinical symptom in the combined treatment group was lower than either of the rest two groups respectively (<0.05); and the scores for abdominal pain, abdominal distention and incomplete bowel movement in the acupoint application group were lower than those in the western medication group separately (<0.05). After 7 and 28 days of treatment, the score of each item in IBS-QOL was increased as compared with that before treatment in each group (<0.05). After 7 days of treatment, except the scores for heterosexual relationship and human relations, scores of the other items, other scores of IBS-QOL in the combined treatment group were higher than those in the western medication group separately (<0.05); while the scores of anxiety and behavior disorder in the acupoint application group were higher than those in the western medication group (<0.05). After 28 days of treatment, the each score of IBS-QOL in the combined treatment group was higher than the other two groups respectively (<0.05), while the scores of anxiety, behavior disorder, dietary control, social reaction and human relations in the acupoint application group were all higher than the western medication group (<0.05). After treatment, the levels of and T lymphocytes and the ratio of /in peripheral blood, as well as the expressions of 5-HT4R mRNA in colon tissue were all increased in each group (<0.05), but the levels of T lymphocyte and 5-HT3R mRNA expressions in colon tissue were reduced in each group (<0.05). After treatment, regarding the levels of and T lymphocytes and the ratio of /in peripheral blood, as well as the expressions of 5-HT4R mRNA in colon tissue, the values in the combined treatment group were all higher than either of the rest two groups respectively (<0.05), while the values in the acupoint application group were higher than the western medication group (<0.05). Concerning to the level of T lymphocytes and 5-HT3R mRNA expression, the values in the combined treatment group were lower than the rest two groups respectively (<0.05), and the values in the acupoint application group were lower than the western medication group (<0.05).
The combined treatment with the fire needling therapy with filiform needle and the acupoint application therapy effectively relieves the clinical symptoms, improves the quality of life and strengthens the immunity in the patients with IBS-D. The therapeutic effect of this combined regimen is better than either simple acupoint application therapy or the oral medication of pinaverium bromide. The mechanism may be related to the regulation of the levels of T lymphocyte subsets and the modulation of the expressions of 5-HT3R and 5-HT4R mRNA in colon tissue.
比较火针结合穴位敷贴疗法、单纯穴位敷贴疗法及匹维溴铵片治疗腹泻型肠易激综合征(IBS-D)脾虚湿盛证的临床疗效,并探讨其对IBS-D的改善机制。
将150例脾虚湿盛型IBS-D患者随机分为联合治疗组(50例,脱落14例)、穴位敷贴组(50例,脱落16例)和西药组(50例,脱落13例)。西药组口服匹维溴铵片,每次50mg,每日3次。穴位敷贴组将中药粉与鲜姜汁混合制成的膏药贴于神阙穴(CV8),每2天1次。联合治疗组在穴位敷贴组治疗的基础上,用毫针行火针治疗天枢穴(ST25)、上巨虚穴(ST37)、阴陵泉穴(SP9)和大肠俞穴(BL25),每2天1次。各组治疗疗程均为4周。分别于治疗前、治疗7天和28天后观察各组临床症状评分及肠易激综合征生活质量量表(IBS-QOL)评分。于治疗前及治疗28天后,依次检测患者外周血中、T淋巴细胞水平及/比值;并分别检测各组结肠黏膜组织中5-HT3R mRNA和5-HT4R mRNA的表达。
与治疗前比较,各组治疗7天和28天后腹痛、腹胀、排便次数、大便性状及排便不尽感评分均降低(<0.05),穴位敷贴组治疗7天后腹痛评分及西药组治疗7天后腹痛、腹胀评分除外。治疗7天后,联合治疗组腹胀、排便次数及大便性状评分均低于西药组(<0.05)。治疗28天后,联合治疗组各临床症状评分均低于其余两组(<0.05);穴位敷贴组腹痛、腹胀及排便不尽感评分均低于西药组(<0.05)。治疗7天和28天后,各组IBS-QOL各项目评分均高于治疗前(<0.05)。治疗7天后,联合治疗组IBS-QOL除异性关系和人际关系评分外,其余各项目评分均高于西药组(<0.05);穴位敷贴组焦虑和行为障碍评分高于西药组(<0.05)。治疗28天后,联合治疗组IBS-QOL各评分均高于其余两组(<0.05),穴位敷贴组焦虑、行为障碍、饮食控制、社会反应及人际关系评分均高于西药组(<0.05)。治疗后,各组外周血中、T淋巴细胞水平及/比值,以及结肠组织中5-HT4R mRNA表达均升高(<0.05),但各组结肠组织中T淋巴细胞水平及5-HT3R mRNA表达降低(<0.05)。治疗后,联合治疗组外周血中、T淋巴细胞水平及/比值,以及结肠组织中5-HT4R mRNA表达均高于其余两组(<0.05),穴位敷贴组高于西药组(<0.05)。关于T淋巴细胞水平及5-HT3R mRNA表达,联合治疗组低于其余两组(<0.05),穴位敷贴组低于西药组(<0.05)。
毫针火针与穴位敷贴联合治疗能有效缓解IBS-D患者的临床症状,提高生活质量,增强机体免疫力。该联合方案的治疗效果优于单纯穴位敷贴疗法或匹维溴铵口服给药。其机制可能与调节T淋巴细胞亚群水平及结肠组织中5-HT3R和5-HT4R mRNA表达有关。